Delhi-based health-tech startup Gabify, a platform dedicated to solving neurodevelopmental challenges in children, has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures.
The startup has also been awarded Rs 25 lakh under the Nidhi Seed Support Scheme by GHRTBI (G H Raisoni Technology Business Incubator Foundation), a government-backed initiative that supports early-stage startups with high innovation potential.
The capital raised will be strategically deployed towards clinical validation, technology enhancement, and team expansion, key priorities aimed at accelerating growth and building a sustainable revenue model.
Gabify is part of the 4th cohort of IPV IdeaSchool, an exclusive cohort-based incubator programme designed for Pre-Seed to Seed-stage startups. Having successfully conducted 5 cohorts so far, the programme has supported a strong pipeline of emerging startups.
The startup is India's first fully hosted speech and neurodevelopmental condition SaaS ecosystem. Gabify has an end-to-end AI screening and therapy platform specifically designed for speech and neurological disorders such as Autism and ADHD.
Gabify's use of dual-AI (voice + vision) provides a comprehensive view of the child's speech patterns as well as facial expressions, eye gaze, and behaviours based on 189+ clinically validated criteria that are aligned with DSM-5 and CARS. The system employs a human-in-loop (HITL) approach for clinical validation to review all AI-based clinical outputs to ensure they are accurate and reflect expert professional input. Although the model has been designed for Bharat but has the potential to be scaled globally considering that it is multilingual, low bandwidth, and suited to rural communities.
